Stock market sell-offs are often great opportunities to buy dividend stocks. One of the easiest ways to capitalize on this ...

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research ...

Incyte's experimental skin disease drug met the main goal of two separate late-stage trials, the company said on Monday, but its shares declined 11% as the drug significantly underperformed prior ...

Incyte's experimental skin disease drug met the main goal of two separate late-stage trials, but data showed that it was not as effective as in its prior studies, sending the drugmaker's shares down ...